Cable Hill Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Cable Hill Partners's BMY Position: Q1 2025 in Review
Cable Hill Partners reduced its Bristol-Myers Squibb (BMY) stake by 12% in Q1 2025, selling an estimated $33.7K and leaving 4,137 shares worth $208K. The position accounts for 0.02% of the portfolio, ranked #206.
Cable Hill Partners first reported a position in BMY in Q4 2014 and has held it in 23 quarters since. The position peaked at $296K in Q3 2024. 2,479 funds tracked by Wall St. Rank hold BMY as of Q1 2025.
- Cable Hill Partners held 4,137 shares of Bristol-Myers Squibb worth $208K as of Q1 2025.
- Cable Hill Partners sold 578 Bristol-Myers Squibb shares in Q1 2025, an estimated $33.7K.
- Bristol-Myers Squibb made up 0.02% of Cable Hill Partners's portfolio in Q1 2025, its #206 holding.
- Cable Hill Partners first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 23 quarters since.
- Cable Hill Partners's Bristol-Myers Squibb position peaked at $296K in Q3 2024.
- 2,479 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.
Based on Cable Hill Partners's 13F filing for Q1 2025, filed 2 May 2025.